NEW YORK (Reuters Health) – Chemotherapy-induced delayed nausea remains a significant problem, despite the availability of second-generation antiemetics, researchers say. In a study they conducted, over half of…
NEW YORK (Reuters Health) – In advanced ovarian cancer, extensive lymph node dissection in a second-look operation does not improve survival, Italian researchers say. Their randomized trial addressed…
NEW YORK (Reuters Health) – Patients with esophageal cancer appear to have equally good survival after minimally invasive esophagectomy (MIE) or traditional open surgery, according to a new…
Russ Altman, MD, PhD, Professor & Chair, Bioengineering, Stanford University, discusses the therapeutic advantages to be gained from integrating molecular, cellular, EMR and population data to understand how…
David Albert, MD, Founder & Chief Medical Officer, AliveCor, demonstrates the AliveCor ECG, an iPhone accessory that will allow both physicians and patients to capture and transmit clinical…
Time is crucial after an acute heart attack. Many patients undergo a primary percutaneous coronary intervention or PCI to open blocked coronary arteries. Cardiologists do this by implanting…
Ajay Verma, MD, PhD, VP, Neurodegeneration & Translational Neurology, Biogen Idec, talks about the importance of understanding programmed cell death in treating neurodegenerative disease. Filmed at FutureMed, in…
NEW YORK (Reuters Health) – In women with hormone-receptor-positive metastatic breast cancer, combining anastrozole and fulvestrant extends progression-free and overall survival, according to a paper released online today…
